121 related articles for article (PubMed ID: 17981724)
1. Dipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylation.
McGuinness C; Wesley UV
Front Biosci; 2008 Jan; 13():2435-43. PubMed ID: 17981724
[TBL] [Abstract][Full Text] [Related]
2. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.
Wesley UV; Albino AP; Tiwari S; Houghton AN
J Exp Med; 1999 Aug; 190(3):311-22. PubMed ID: 10430620
[TBL] [Abstract][Full Text] [Related]
3. Methylation status of the SOCS3 gene in human malignant melanomas.
Tokita T; Maesawa C; Kimura T; Kotani K; Takahashi K; Akasaka T; Masuda T
Int J Oncol; 2007 Mar; 30(3):689-94. PubMed ID: 17273770
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells.
Pethiyagoda CL; Welch DR; Fleming TP
Clin Exp Metastasis; 2000; 18(5):391-400. PubMed ID: 11467771
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
6. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
Hoon DS; Spugnardi M; Kuo C; Huang SK; Morton DL; Taback B
Oncogene; 2004 May; 23(22):4014-22. PubMed ID: 15064737
[TBL] [Abstract][Full Text] [Related]
7. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.
Furuta J; Nobeyama Y; Umebayashi Y; Otsuka F; Kikuchi K; Ushijima T
Cancer Res; 2006 Jun; 66(12):6080-6. PubMed ID: 16778180
[TBL] [Abstract][Full Text] [Related]
8. ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma.
Guan X; Sagara J; Yokoyama T; Koganehira Y; Oguchi M; Saida T; Taniguchi S
Int J Cancer; 2003 Nov; 107(2):202-8. PubMed ID: 12949795
[TBL] [Abstract][Full Text] [Related]
9. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells.
Wesley UV; Tiwari S; Houghton AN
Int J Cancer; 2004 May; 109(6):855-66. PubMed ID: 15027119
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors.
Gonzalgo ML; Bender CM; You EH; Glendening JM; Flores JF; Walker GJ; Hayward NK; Jones PA; Fountain JW
Cancer Res; 1997 Dec; 57(23):5336-47. PubMed ID: 9393758
[TBL] [Abstract][Full Text] [Related]
11. Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.
Nobeyama Y; Okochi-Takada E; Furuta J; Miyagi Y; Kikuchi K; Yamamoto A; Nakanishi Y; Nakagawa H; Ushijima T
Int J Cancer; 2007 Jul; 121(2):301-7. PubMed ID: 17372906
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation.
Stengel S; Fiebig U; Kurth R; Denner J
Genes Chromosomes Cancer; 2010 May; 49(5):401-11. PubMed ID: 20095041
[TBL] [Abstract][Full Text] [Related]
15. Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells.
Tsuji T; Sugahara K; Tsuruda K; Uemura A; Harasawa H; Hasegawa H; Hamaguchi Y; Tomonaga M; Yamada Y; Kamihira S
Int J Hematol; 2004 Oct; 80(3):254-60. PubMed ID: 15540901
[TBL] [Abstract][Full Text] [Related]
16. Silencing of interferon regulatory factor gene 6 in melanoma.
Nobeyama Y; Nakagawa H
PLoS One; 2017; 12(9):e0184444. PubMed ID: 28877249
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells.
Wada K; Maesawa C; Akasaka T; Masuda T
J Invest Dermatol; 2004 Mar; 122(3):805-11. PubMed ID: 15086568
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation profiling of 30 genes in human malignant melanoma.
Furuta J; Umebayashi Y; Miyamoto K; Kikuchi K; Otsuka F; Sugimura T; Ushijima T
Cancer Sci; 2004 Dec; 95(12):962-8. PubMed ID: 15596045
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
Liu S; Ren S; Howell P; Fodstad O; Riker AI
Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
[TBL] [Abstract][Full Text] [Related]
20. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
